Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related VC
Benzinga's Top Upgrades, Downgrades For July 31, 2017
Report: Amazon Planning Third Metro Detroit Distribution Center
Related
Earnings Scheduled For June 13, 2017
Exclusive: Biopharmx CFO Talks Trial Results, Competitive Prospects For BPMX Acne Treatment

Analysts at Baird initiated coverage on Visteon Corp (NYSE: VC) with a Outperform rating. The target price for Visteon is set to $123. Visteon shares closed at $100.30 yesterday.

Analysts at Sterne Agee CRT initiated coverage of BioPharmX Corp (NYSE: BPMX) with a Buy rating. The target price for BioPharmX is set to $3.50. BioPharmX shares closed at $1.43 yesterday.

Analysts at William Blair initiated coverage on WhiteWave Foods Co (NYSE: WWAV) with a Outperform rating. WhiteWave Foods shares closed at $45.41 yesterday.

Canaccord Genuity initiated coverage on vTv Therapeutics Inc (NASDAQ: VTVT) with a Buy rating. The target price for vTv Therapeutics is set to $15. vTv Therapeutics shares closed at $9.50 yesterday.

UBS initiated coverage on Healthways, Inc. (NASDAQ: HWAY) with a Neutral rating. The target price for Healthways is set to $13. Healthways shares closed at $11.77 yesterday.

Analysts at Argus Research initiated coverage on Gannett Co Inc (NYSE: GCI) with a Hold rating. Gannett shares closed at $13.51 yesterday.

Analysts at Redburn initiated coverage on Priceline Group Inc (NASDAQ: PCLN) with a Buy rating. Priceline Group shares closed at $1,240.37 yesterday.

Latest Ratings for VC

DateFirmActionFromTo
Aug 2017BarclaysMaintainsEqual-Weight
Jul 2017BMO CapitalMaintainsOutperform
Jul 2017UBSDowngradesBuyNeutral

View More Analyst Ratings for VC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GCI + BPMX)

View Comments and Join the Discussion!